819 related articles for article (PubMed ID: 12521697)
1. First-trimester pregnancy scanning as a screening tool for high-risk and abnormal pregnancies in a district general hospital setting.
Drysdale K; Ridley D; Walker K; Higgins B; Dean T
J Obstet Gynaecol; 2002 Mar; 22(2):159-65. PubMed ID: 12521697
[TBL] [Abstract][Full Text] [Related]
2. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.
Spencer K; Nicolaides KH
BJOG; 2003 Mar; 110(3):276-80. PubMed ID: 12628267
[TBL] [Abstract][Full Text] [Related]
3. [Ultrasound screening for Down syndrome and other chromosomal abnormalities by fetal nuchal translucency measurement between 11-14 weeks of gestation].
Dimitrova V; Markov D; Chernev T; Karag'ozova Zh; Mazneĭkova V; Andonova S; Vŭzharova R
Akush Ginekol (Sofiia); 2005; 44(1):32-7. PubMed ID: 15853009
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of 12-13-week scan for early diagnosis of fetal congenital anomalies in the cell-free DNA era.
Kenkhuis MJA; Bakker M; Bardi F; Fontanella F; Bakker MK; Fleurke-Rozema JH; Bilardo CM
Ultrasound Obstet Gynecol; 2018 Apr; 51(4):463-469. PubMed ID: 28397377
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of fetal non-chromosomal abnormalities on routine ultrasound examination at 11-13 weeks' gestation.
Syngelaki A; Hammami A; Bower S; Zidere V; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2019 Oct; 54(4):468-476. PubMed ID: 31408229
[TBL] [Abstract][Full Text] [Related]
6. The implementation of first-trimester scanning at 10-13 weeks' gestation and the measurement of fetal nuchal translucency thickness in two maternity units.
Pandya PP; Goldberg H; Walton B; Riddle A; Shelley S; Snijders RJ; Nicolaides KH
Ultrasound Obstet Gynecol; 1995 Jan; 5(1):20-5. PubMed ID: 7850584
[TBL] [Abstract][Full Text] [Related]
7. [Ultrasound screening and diagnosis of fetal structural abnormalities between 11-14 gestational weeks].
Markov D; Chernev T; Dimitrova V; Mazneĭkova V; Leroy Y; Jacquemyn Y; Ramaekers P; Van Bulck B; Loquet P
Akush Ginekol (Sofiia); 2004; 43(3):3-10. PubMed ID: 15341249
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of ultrasound screening for fetal structural abnormalities during the first and second trimester of pregnancy in low-risk and unselected populations.
Buijtendijk MF; Bet BB; Leeflang MM; Shah H; Reuvekamp T; Goring T; Docter D; Timmerman MG; Dawood Y; Lugthart MA; Berends B; Limpens J; Pajkrt E; van den Hoff MJ; de Bakker BS
Cochrane Database Syst Rev; 2024 May; 5(5):CD014715. PubMed ID: 38721874
[TBL] [Abstract][Full Text] [Related]
9. Screening for structural fetal anomalies during the nuchal translucency ultrasound examination.
Weiner Z; Goldstein I; Bombard A; Applewhite L; Itzkovits-Eldor J
Am J Obstet Gynecol; 2007 Aug; 197(2):181.e1-5. PubMed ID: 17689643
[TBL] [Abstract][Full Text] [Related]
10. Role of ultrasound evaluation of nuchal translucency in prenatal diagnosis.
Borruto F; Comparetto C; Acanfora L; Bertini G; Rubaltelli FF
Clin Exp Obstet Gynecol; 2002; 29(4):235-41. PubMed ID: 12635737
[TBL] [Abstract][Full Text] [Related]
11. Screening for major structural abnormalities at the 11- to 14-week ultrasound scan.
Souka AP; Pilalis A; Kavalakis I; Antsaklis P; Papantoniou N; Mesogitis S; Antsaklis A
Am J Obstet Gynecol; 2006 Feb; 194(2):393-6. PubMed ID: 16458635
[TBL] [Abstract][Full Text] [Related]
12. Fetal karyotyping after 28 weeks of gestation for late ultrasound findings in a low risk population.
Drummond CL; Gomes DM; Senat MV; Audibert F; Dorion A; Ville Y
Prenat Diagn; 2003 Dec; 23(13):1068-72. PubMed ID: 14691994
[TBL] [Abstract][Full Text] [Related]
13. Screening for Down syndrome based on maternal age or fetal nuchal translucency: a randomized controlled trial in 39,572 pregnancies.
Saltvedt S; Almström H; Kublickas M; Valentin L; Bottinga R; Bui TH; Cederholm M; Conner P; Dannberg B; Malcus P; Marsk A; Grunewald C
Ultrasound Obstet Gynecol; 2005 Jun; 25(6):537-45. PubMed ID: 15912479
[TBL] [Abstract][Full Text] [Related]
14. Optimising the timing for nuchal translucency measurement.
Mulvey S; Baker L; Edwards A; Oldham J; Shekleton P; Wallace EM
Prenat Diagn; 2002 Sep; 22(9):775-7. PubMed ID: 12224069
[TBL] [Abstract][Full Text] [Related]
15. Fetal structural anomaly screening at 11-14 weeks of gestation at Maharaj Nakorn Chiang Mai Hospital.
Srisupundit K; Tongsong T; Sirichotiyakul S; Chanprapaph P
J Med Assoc Thai; 2006 May; 89(5):588-93. PubMed ID: 16756041
[TBL] [Abstract][Full Text] [Related]
16. [First trimester ultrasound screening for structural and chromosomal anomalies in multiple pregnancy].
Markov D; Chernev T; Dimitrova V; Masneĭkova V; Leroy Y; Jacquemyn Y; Ramaekers P; Van Bulck B; Loquet P
Akush Ginekol (Sofiia); 2004; 43(5):11-8. PubMed ID: 15518278
[TBL] [Abstract][Full Text] [Related]
17. Two-stage ultrasonography in screening for fetal anomalies at 13-14 and 18-22 weeks of gestation.
Taipale P; Ammälä M; Salonen R; Hiilesmaa V
Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1141-6. PubMed ID: 15548146
[TBL] [Abstract][Full Text] [Related]
18. Does fetal screening affect women's worries about the health of their baby? A randomized controlled trial of ultrasound screening for Down's syndrome versus routine ultrasound screening.
Georgsson Ohman S; Saltvedt S; Grunewald C; Waldenström U
Acta Obstet Gynecol Scand; 2004 Jul; 83(7):634-40. PubMed ID: 15225187
[TBL] [Abstract][Full Text] [Related]
19. Sequential screening for trisomy 21 by nuchal translucency measurement in the first trimester and maternal serum biochemistry in the second trimester in a low-risk population.
Schuchter K; Hafner E; Stangl G; Ogris E; Philipp K
Ultrasound Obstet Gynecol; 2001 Jul; 18(1):23-5. PubMed ID: 11489220
[TBL] [Abstract][Full Text] [Related]
20. Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years prospective experience.
Spencer K; Spencer CE; Power M; Dawson C; Nicolaides KH
BJOG; 2003 Mar; 110(3):281-6. PubMed ID: 12628268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
